205 related articles for article (PubMed ID: 2346339)
1. Response to treatment of congenital adrenal hyperplasia in infancy.
Young MC; Hughes IA
Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
[TBL] [Abstract][Full Text] [Related]
2. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE; Sizonenko PC
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[TBL] [Abstract][Full Text] [Related]
3. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
Silva IN; Oliveira-Júnior DF; Simal CJ; Viana MB; Chagas AJ
Indian J Pediatr; 1994; 61(4):341-6. PubMed ID: 8002061
[TBL] [Abstract][Full Text] [Related]
4. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
Cattani A; Mahaha D; Michaud P; Rodríguez JA; López JM; García H; Foradori A; Velásquez CG
Rev Chil Pediatr; 1984; 55(6):374-9. PubMed ID: 6536989
[No Abstract] [Full Text] [Related]
5. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
Pincus DR; Kelnar CJ; Wallace AM
J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
Winterer J; Chrousos GP; Loriaux DL; Cutler GB
J Pediatr; 1985 Jan; 106(1):137-42. PubMed ID: 3871229
[TBL] [Abstract][Full Text] [Related]
7. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.
Hughes IA; Dyas J; Robinson J; Walker RF; Fahmy DR
Ann N Y Acad Sci; 1985; 458():193-202. PubMed ID: 3879122
[No Abstract] [Full Text] [Related]
8. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
Frisch H; Parth K; Schober E; Swoboda W
Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
[TBL] [Abstract][Full Text] [Related]
9. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
Sólyom J; Hosszu E; Gács G
Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
[TBL] [Abstract][Full Text] [Related]
10. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
Vavrinec J; Dvorák P; Zizkovský V; Kopecký A; Pospísilová D; Starý J
Cesk Pediatr; 1983 Sep; 38(9):533-6. PubMed ID: 6315246
[No Abstract] [Full Text] [Related]
11. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.
Silva IN; Kater CE; Cunha CF; Viana MB
Arch Dis Child; 1997 Sep; 77(3):214-8. PubMed ID: 9370898
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia.
Keenan BS; Eberle AE; Lin TH; Clayton GW
J Pediatr; 1990 Jan; 116(1):133-6. PubMed ID: 2153199
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
Arisaka O; Hosaka A; Arisaka M; Shimura N; Nakayama Y; Yamashiro Y; Yabuta K
Acta Paediatr; 1992 Mar; 81(3):268-9. PubMed ID: 1387331
[No Abstract] [Full Text] [Related]
14. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
Winter JS; Couch RM
Ann N Y Acad Sci; 1985; 458():165-73. PubMed ID: 3879120
[No Abstract] [Full Text] [Related]
15. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
Laue L; Merke DP; Jones JV; Barnes KM; Hill S; Cutler GB
J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
[TBL] [Abstract][Full Text] [Related]
16. [Adrenalectomy as therapy in refractory adrenogenital syndrome].
von Mühlendahl KE; Sippell WG
Monatsschr Kinderheilkd; 1989 Jun; 137(6):341-4. PubMed ID: 2761548
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical adenoma associated with inadequately treated congenital adrenal hyperplasia.
Kurtoğlu S; Atabek ME; Keskin M; Patiroglu TE
J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1311-4. PubMed ID: 14714757
[TBL] [Abstract][Full Text] [Related]
18. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
von Schnakenburg K; Bidingmaier F; Knorr D
Monatsschr Kinderheilkd (1902); 1977 May; 125(5):579-80. PubMed ID: 876244
[No Abstract] [Full Text] [Related]
19. Management of congenital adrenal hyperplasia.
Antony G
Lancet; 1984 May; 1(8385):1073. PubMed ID: 6143998
[No Abstract] [Full Text] [Related]
20. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
Sólyom J
Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
